<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32577867</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.</ArticleTitle><Pagination><StartPage>3310</StartPage><EndPage>3318</EndPage><MedlinePgn>3310-3318</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10003-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Poor monitoring of respiratory function may lead to late initiation of non-invasive ventilation (NIV) in patients with motor neuron diseases (MND). Monitoring could be improved by remotely assessing hypoventilation symptoms between clinic visits. We aimed to determine which patient-reported hypoventilation symptoms are best for screening reduced respiratory function in patients with MND, and compared them to the respiratory domain of the amyotrophic lateral sclerosis functional rating scale (ALSFRS-R).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective multi-center study included 100 patients with MND, who were able to perform a supine vital capacity test. Reduced respiratory function was defined as a predicted supine vital capacity&#x2009;&#x2264;&#x2009;80%. We developed a 14-item hypoventilation symptom questionnaire (HYSQ) based on guidelines, expert opinion and think-aloud interviews with patients. Symptoms of the HYSQ were related to dyspnea, sleep quality, sleepiness/fatigue and pneumonia. The diagnostic performances of these symptoms and the ALSFRS-R respiratory domain were determined from the receiver operating characteristic (ROC) curves, area under the curve (AUC), sensitivity, specificity, predictive values and accuracy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Dyspnea-related symptoms (dyspnea while eating/talking, while lying flat and during light activity) were combined into the MND Dyspnea Scale (MND-DS). ROC curves showed that the MND-DS had the best diagnostic performance, with the highest AUC&#x2009;=&#x2009;0.72, sensitivity&#x2009;=&#x2009;75% and accuracy&#x2009;=&#x2009;71%. Sleep-quality symptoms, sleepiness/fatigue-related symptoms and the ALSFRS-R respiratory domain showed weak diagnostic performance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The diagnostic performance of the MND-DS was better than the respiratory domain of the ALSFRS-R for screening reduced respiratory function in patients with MND, and is, therefore, the preferred method for (remotely) monitoring respiratory function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Helleman</LastName><ForeName>Jochem</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruitwagen-van Reenen</LastName><ForeName>Esther T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakers</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruithof</LastName><ForeName>Willeke J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Groenestijn</LastName><ForeName>Annerieke C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaspers Focks</LastName><ForeName>Rineke J H</ForeName><Initials>RJH</Initials><AffiliationInfo><Affiliation>Roessingh, Center for Rehabilitation, Enschede, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Grund</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Basalt, Center for Rehabilitation, Den Haag, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visser-Meily</LastName><ForeName>Johanna M A</ForeName><Initials>JMA</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beelen</LastName><ForeName>Anita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1269-0710</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation, Physical Therapy Science and Sports, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, and De Hoogstraat Rehabilitation, Utrecht, The Netherlands. j.a.j.beelen@umcutrecht.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016-51</GrantID><Agency>ALS Foundation Netherlands</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Dyspnea</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Patient-reported outcome measure</Keyword><Keyword MajorTopicYN="N">Respiratory function</Keyword><Keyword MajorTopicYN="N">Vital capacity</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32577867</ArticleId><ArticleId IdType="pmc">PMC7578163</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10003-5</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10003-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corcia P, Pradat PF, Salachas F, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9(1):59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17924236</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Ludolph AC. Non-invasive ventilation in amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2019;12:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589990</ArticleId><ArticleId IdType="pubmed">31258624</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS A pilot placebo-controlled study. Neurology. 2016;87:1878&#x2013;1883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5100714</ArticleId><ArticleId IdType="pubmed">27581221</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Montini A, Lunetta C, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:556&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">29266547</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE (2016) Motor neuron disease: assessment and Motor neurone disease: assessment and management NICE guideline. www.nice.org.uk/guidance/ng42. Accessed 30 Aug 2019</Citation></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) Neurology. 2009;73:1218&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter SK, Johnson M, Clowes M, et al. Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review. Amyotroph Lateral Scler Front Degener. 2019;20(7&#x2013;8):461&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">31204525</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges M, Golmard JL, Llontop C, et al. Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: Single-centre, retrospective, descriptive study in a national reference centre. Amyotroph Lateral Scler Front Degener. 2017;18(1&#x2013;2):46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">27978772</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry. 2012;83(4):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">22013242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritsma BR, Berger MJ, Charland DA, et al. NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. Can J Neurol Sci. 2010;37(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">20169774</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill CL, Williams TL, Peel ET, et al. Non-invasive ventilation in motor neuron disease: an update of current UK practice. J Neurol Neurosurg Psychiatry. 2012;83(4):371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">21849339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W, Anderson F, Gowda N, Miller R. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Mot Neuron Disord. 2004;5(4):240&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">15799554</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Burke T, Vajda A, Heverin M, Hardiman O. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(5):381&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">27888187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, De Carvalho M. The R of ALSFRS-R: Does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph Lateral Scler Front Degener. 2015;16(1&#x2013;2):120&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">25205208</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Berry JD, Chan J, et al. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. J Neurol. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32125520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design. Muscle Nerve. 2006;33(1):127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">16258948</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann F, Henderson RD, Morrison SC, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">19452343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, Rosenfeld J, Moore DH, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">11676995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest. 2002;121:436&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">11834654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, de Carvalho M. Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study. Amyotroph Lateral Scler Front Degener. 2017;18(1&#x2013;2):86&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">27915482</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Vasta R, Moglia C, et al. Prognostic role of slow vital capacity in amyotrophic lateral sclerosis. J Neurol. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32052165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke S, Bullock R, Williams T, Shaw P, Gibson G. Noninvasive ventilation in ALS Indications and effect on quality of life. Neurology. 2003;61:171&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">12874394</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, Lovitt S, Gowda N, et al. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler. 2006;7(2):80&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">16753971</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Lapin BR, Pioro EP, Aboussouan LS. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology. 2019;93(3):306&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">31182506</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, et al. Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotroph Lateral Scler Front Degener. 2018;19(5&#x2013;6):331&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">29661084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilanus TBM, Groothuis JT, Ten Broek-Pastoor JMC, et al. Respiratory assessment of ALS patients: a nationwide survey of current Dutch practice. J Neuromuscul Dis. 2018;5(4):431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">30372689</ArticleId></ArticleIdList></Reference><Reference><Citation>Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep. 2019;11:97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6701267</ArticleId><ArticleId IdType="pubmed">31496852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardi J, Prigent H, Adala A, et al. Nocturnal oximetry and transcutaneous carbon dioxide in home-ventilated neuromuscular patients. Respir Care. 2012;57(9):1425&#x2013;1430.</Citation><ArticleIdList><ArticleId IdType="pubmed">22348449</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt S, Schreiber S, Kollewe K, et al. Dyspnea in amyotrophic lateral sclerosis: the Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment. Respir Med. 2019;154:116&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">31234039</ArticleId></ArticleIdList></Reference><Reference><Citation>Geronimo A, Simmons Z. Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20(5&#x2013;6):348&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">30957547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>